Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


nib to acquire TOWER Medical Insurance in NZ

ASX Announcement


Date 2 November 2012
Subject nib to acquire TOWER Medical Insurance in New Zealand

nib holdings limited (ASX: NHF) today announced that it had agreed to acquire TOWER Medical Insurance Limited (TOWER Medical) in New Zealand for approximately NZ$102 million (A$80 million). The purchase price represents a multiple of 0.85x embedded value as at 31 March 2012. The acquisition is subject to New Zealand regulatory approvals and the purchase price may be adjusted based on the completed accounts.

TOWER Medical, a wholly-owned subsidiary of TOWER Limited (ASX: TWR, NZX: TWR), is New Zealand’s second-largest health insurer, providing cover to approximately 169,000 people and has annual premium revenue of approximately NZ$140 million. TOWER Medical has net assets of approximately NZ$64 million, embedded value was NZ$119.4 million as at 31 March 2012. TOWER Medical made NZ$6.8 million NPAT for 1H12 and has approximately NZ$10 million in surplus capital.

nib’s Managing Director, Mark Fitzgibbon, said the acquisition is in line with nib’s strategy of growing international earnings.

“nib has been investigating opportunities in New Zealand for some time. TOWER Medical meets nib’s strict investment criteria in terms of strategic rationale and return on investment,” Mr Fitzgibbon said.

“With a market share of approximately 13%, TOWER Medical provides an opportunity to emulate the success nib has achieved in Australia since its listing in 2007 through brand building, product design, distribution and outstanding customer service,” he said.

“In addition to leveraging our own core capabilities, TOWER Medical has had success working with financial advisers and we look forward to working with them to further develop this important distribution channel and grow market share,” Mr Fitzgibbon said.

“New Zealand is a market with similarities to the Australian health insurance landscape early last decade. There’s one dominant player, no obvious competitive tension and the Government knows budget constraints mean there must be more future private funding of healthcare,” he added.

The purchase price will result in substantial, immediate accretion to earnings per share and return on equity.

nib and TOWER Limited have entered into an exclusive 10 year white label distribution agreement supporting the sale of bundled life and health products.

TOWER Group Managing Director Rob Flannagan said TOWER looked forward to working with nib and building a long-term relationship that would deliver benefits to TOWER customers through the insights, expertise and strong track record in medical insurance that nib will bring to the New Zealand market.

“nib’s customer service expertise and strong track record in medical insurance will bring obvious benefits to our customers and the broader New Zealand market,” Mr Flanagan said.

“In addition, nib provides the financial advisers who distribute TOWER products and services with access to a provider with scale and international expertise, as well as the capability to deliver innovative products and services,” he said.

nib will fund the transaction through surplus capital and a NZ$70 million senior debt facility. Post transaction gearing (debt/debt + equity) of 16% is consistent with the range of 20% to 30% contained within nib’s Capital Management Plan.

nib has appointed Jayne Drinkwater (former nib Chief Operating Officer and Chief Marketing Officer from 2003 - 2008) as interim CEO New Zealand, and Glenn Treadwell (current nib Group Financial Controller) as interim CFO New Zealand. Both will be based in Auckland, where TOWER Medical has its head office.

nib was advised by J.P. Morgan and Simpson Grierson.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Royal Society: Review Finds Community Water Fluoridation Safe And Effective

A review of the scientific evidence for and against the efficacy and safety of fluoridation of public water supplies has found that the levels of fluoridation used in New Zealand create no health risks and provide protection against tooth decay. More>>

ALSO:

Scoop Business: Croxley Calls Time On NZ Production In Face Of Cheap Imports

Croxley Stationery, whose stationery brands include Olympic, Warwick and Collins, plans to cease manufacturing in New Zealand because it has struggled to compete with lower-cost imports in a market where the printed word is giving way to electronic communications. More>>

ALSO:

Prefu Roundup: Forecasts Revised, Surplus Intact

The National government heads into the election with its Budget surplus target broadly intact, delivering a set of economic and fiscal forecasts marginally revised from May to reflect weaker commodity prices and a lower tax take. More>>

ALSO:

Convention Centre: Major New SkyCity Hotel And Laneway For Auckland

Today SKYCITY Entertainment Group Limited revealed plans to build a new hotel and pedestrian laneway of bars, restaurants and boutique shopping on land it owns in the Nelson and Hobson Streets block, expanding the SKYCITY Entertainment Precinct. More>>

ALSO:

Igniting The Spark: Bringing The Digital Enabler To Life

Changing a name is, relatively speaking, the easy part of a re-invention. Changing a culture, getting all the ducks in a row, turning yourself inside-out to become customer-inspired is a much bigger challenge. More>>

ALSO:

Ebola And NZ: Targeted Screening At Airport But Risk Low

The risk of any cases of Ebola in New Zealand remains very low, but health and border authorities are well prepared... anyone arriving in New Zealand who in the last three weeks has visited countries affected will be screened for symptoms of the disease. More>>

ALSO:

Scoop Business: Brewer Seeking Crowd-Funding Cancels Shareholders’ Dividends

Shareholders in Renaissance Brewing company, the first business to seek equity through crowd-funding in New Zealand, have cancelled their claim on $147,000 of accumulated earnings “to make Renaissance a more attractive investment opportunity.” More>>

ALSO:

Get More From Scoop

 
 
Computer Power Plus

Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news